NCT00242606View on ClinicalTrials.gov

Lamotrigine Versus Levetiracetam in the Initial Monotherapy of Epilepsy

PHASE3CompletedINTERVENTIONAL
Enrollment

409

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

June 30, 2008

Study Completion Date

January 31, 2009

Conditions
Epilepsy
Interventions
DRUG

Lamotrigine

titrate to 200mg over 10 weeks and maintained until end of week 26

DRUG

Levetiracetam

titrate to 2000mg/day over 22 days, maintain until the end of week 26

Trial Locations (1)

35033

Philipps University Marburg Medical Center, Department of Neurology, Marburg

All Listed Sponsors
collaborator

UCB Pharma GmbH

INDUSTRY

lead

Philipps University Marburg

OTHER

NCT00242606 - Lamotrigine Versus Levetiracetam in the Initial Monotherapy of Epilepsy | Biotech Hunter | Biotech Hunter